• Return to Headlines

Shares of Endocyte Inc Has Risen Above Previous 52-Week High

By Shiri Gupta

Endocyte Inc (NASDAQ:ECYT) traded today at a new 52-week high of $16.94. Approximately 103,000 shares have changed hands today, as compared to an average 30-day volume of 1.6 million shares.

Endocyte Inc share prices have moved between a 52-week high of $16.94 and a 52-week low of $1.17 and are now trading 1,327% above that low price at $16.70 per share. Over the last five market days, the 200-day moving average (MA) has gone up 3.1% while the 50-day MA has advanced 3.3%.

Endocyte Inc. is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. The Company uses a proprietary technology to create small molecule drug conjugates, SMDCs, and companion imaging diagnostics that actively target receptors that are over-expressed on diseased cells, relative to healthy cells.

Potential upside of 5.8% exists for Endocyte Inc, based on a current level of $16.70 and analysts' average consensus price target of $17.67. The stock should discover initial support at its 50-day moving average (MA) of $13.55 and subsequent support at its 200-day MA of $7.56.

SmarTrend is tracking the current trend status for Endocyte Inc and will alert subscribers who have ECYT in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows endocyte inc

Ticker(s): ECYT